Medprin: Absorbable regenerated oxidized cellulose hemostatic granules enter clinical trial phase
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Medprin announced that its research and development project "Absorbable Regenerative Oxidized Cellulose Hemostatic Granules" has recently officially entered the clinical trial stage. In surgical procedures, when ligation or other traditional hemostatic methods cannot be performed or are ineffective, this product can be used as an auxiliary hemostatic product to control capillary, venous, and small arterial bleeding
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments